This video examines results of a phase II trial that studied the combination of neratinib plus capecitabine for the treatment of recurrent brain metastases in HER2-positive breast cancer patients.
Rachel A. Freedman, MD, MPH
Advertisement
Articles by Rachel A. Freedman, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Investigational Radioenhancer Shows Feasibility in Stage III NSCLC
2
Subcutaneous Isatuximab May Optimize Multiple Myeloma Treatment Protocols
3
Mechanistic and Translational Insights of CARv3-TEAM-E in Glioblastoma
4
Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma
5